Risk factors of infection of totally implantable venous access port: A retrospective study

被引:2
|
作者
Guan, Xiaonan [1 ]
Yan, He [2 ]
Zhang, Jianjun [1 ]
Li, Yanbing [1 ]
Zhou, Yiming [2 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Ctr Cardiol, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Chaoyang Hosp, Ctr Intervent Dept, 5 Jingyuan Rd, Beijing 100043, Peoples R China
来源
JOURNAL OF VASCULAR ACCESS | 2023年 / 24卷 / 06期
关键词
Totally implantable venous access port; perioperative infection; complication; cancer patient; antibiotics; CLINICAL-PRACTICE; ANTIBIOTIC-PROPHYLAXIS; PRACTICE GUIDELINE; DEVICE PLACEMENT; CANCER; COMPLICATIONS; CATHETER; DIAGNOSIS; SOCIETY; SYSTEMS;
D O I
10.1177/11297298221085230
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Infection is the most frequent complication associated with the use of totally implantable venous access port (TIVAP). This retrospective study was conducted to determine the risk factors affecting TIVAP-related infection. Methods: A total of 1406 patients implanted with TIVAP at our center were included in this retrospective study. Incidence of perioperative infection, patient characteristics and bacteriologic data were retrieved and analyzed. Univariable analyses and multiple logistic regression analyses were used to determine the risk factors. Results: Overall, 72 (5.1%) patients had perioperative infection, and TIVAP was finally removed from 12 (0.85%) patients. There was significantly more hematologic malignancy in the infection group, compared to the non-infection group. Patients with chemotherapy and infection within 30 days before operation also had more infections. There were more inpatients in the infection group than in the non-infection group. The rate of hematoma was higher in the infected patients. Multivariate logistic analysis revealed that hematoma (OR 5.695, p < 0.001), preoperative hospital stay (> 14d) (OR 2.945, p < 0.001), history of chemotherapy (OR 2.628, p = 0.002), history of infection (within 30 days) (OR 4.325, p < 0.001) were independent risk factor for infection. Conclusions: This study demonstrated that hematoma, preoperative hospital stay (> 14d), history of chemotherapy and history of infection (within 30 days) are independent risk factor for all patients.
引用
收藏
页码:1340 / 1348
页数:9
相关论文
共 50 条
  • [21] Power contrast injections through a totally implantable venous power port: A retrospective multicenter study
    Son, Ryong Seong
    Song, Yun Gyu
    Jo, Jeonghyun
    Park, Byeong-Ho
    Jung, Gyoo-sik
    Yun, Jong Hyouk
    PHLEBOLOGY, 2020, 35 (04) : 268 - 272
  • [22] Surgical procedures and complications in placement of totally implantable venous access port in pediatric hemophilia patients: A retrospective analysis
    Cheng, Wei
    Zhang, Jinrui
    Wang, Xipeng
    Liu, Guoqing
    Yao, Wanru
    Wang, Chunli
    Wu, Runhui
    Li, Zhiqiang
    BLOOD CELLS MOLECULES AND DISEASES, 2024, 108
  • [23] Risk factors for complications in cancer patients with totally implantable access ports: A retrospective study and review of the literature
    Bademler, Suleyman
    Ucuncu, Muhammed
    Yildirim, Ilknur
    Karanlik, Hasan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (02) : 702 - 709
  • [24] Outcome of totally implantable venous-access port-related infections
    Vidal, M.
    Genillon, J. P.
    Forestier, E.
    Trouiller, S.
    Pereira, B.
    Mrozek, N.
    Aumeran, C.
    Lesens, O.
    MEDECINE ET MALADIES INFECTIEUSES, 2016, 46 (01): : 32 - 38
  • [25] Totally implantable venous access systems (PORT): Secondary malposition or spontaneous migration
    Milanesi, E
    Capello, C
    Satolli, MA
    Chiappino, I
    Destefanis, M
    DallaMola, A
    Porcile, GF
    Migliaretti, G
    Martinotti, R
    Sandrucci, S
    ANNALS OF ONCOLOGY, 2000, 11 : 25 - 25
  • [26] Risk factors for central venous access port-related infection
    Coskun, Ali Kagan
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2016, 115 (03) : 217 - 217
  • [27] Totally implantable venous access ports (TIVAPs) infection with subcutaneous abscess
    Moron Losada, Sonia
    Macia-Rodriguez, Cristina
    GALICIA CLINICA, 2021, 82 (04): : 241 - 241
  • [28] Risk factors for totally implantable venous access device-associated complications in cystic fibrosis
    McCarthy, C.
    O'Carroll, O.
    O'Brien, M. E.
    McEnery, T.
    Franciosi, A.
    Gunaratnam, C.
    McElvaney, N. G.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 (02) : 429 - 434
  • [29] Risk factors for totally implantable venous access device-associated complications in cystic fibrosis
    C. McCarthy
    O. O’Carroll
    M. E. O’Brien
    T. McEnery
    A. Franciosi
    C. Gunaratnam
    N. G. McElvaney
    Irish Journal of Medical Science (1971 -), 2018, 187 : 429 - 434
  • [30] Totally implantable venous access devices implanted surgically - A retrospective study on early and late complications
    Di Carlo, I
    Cordio, S
    La Greca, G
    Privitera, G
    Russello, D
    Puleo, S
    Latteri, F
    ARCHIVES OF SURGERY, 2001, 136 (09) : 1050 - 1053